High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Blood

• Publication date

  2011-06-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood-2010-11-317610PMID 21487108PMCID PMC3143547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pivotal Advance: Kaposi's sarcoma‐associated herpesvirus (KSHV)‐encoded microRNA specifically induce IL‐6 and IL‐10 secretion by macrophages and monocytes

  2010cited by this paper
• An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.

  2010cited by this paper
• The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease.

  2009cited by this paper
• Castleman Disease: An Update on Classification and the Spectrum of Associated Lesions

  2009cited by this paper
• Contribution of viral and cellular cytokines to Kaposi's sarcoma‐associated herpesvirus pathogenesis

  2008cited by this paper
• Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.

  2008cited by this paper
• Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.

  2008cited by this paper
• Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors

  2008cited by this paper
• Multicentric Castleman's disease in HIV infection: a systematic review of the literature.

  2008cited by this paper
• Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV‐8)‐infected B cells in HIV+ multicentric Castleman disease (MCD)

  2008cited by this paper
• Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.

  2007cited by this paper
• Brief Communication: Rituximab in HIV-Associated Multicentric Castleman Disease

  2007cited by this paper
• Reactivation of Kaposi's sarcoma‐associated herpesvirus by natural products from Kaposi's sarcoma endemic regions

  2007cited by this paper
• Virus-Associated Tumor Imaging by Induction of Viral Gene Expression

  2007cited by this paper
• Revised response criteria for malignant lymphoma.

  2007cited by this paper
• Hypoxia enhances the phosphorylation and cytotoxicity of ganciclovir and zidovudine in Kaposi's sarcoma-associated herpesvirus infected cells.

  2007cited by this paper
• Simultaneous Detection of Eight Analytes in Human Serum by Two Commercially Available Platforms for Multiplex Cytokine Analysis

  2007cited by this paper
• Successful treatment of a patient with HIV‐associated multicentric Castleman disease (MCD) with thalidomide

  2004cited by this paper
• Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.

  2004cited by this paper
• Failure of cidofovir in HIV-associated multicentric Castleman disease.

  2004cited by this paper
• Dissection of the Kaposi's Sarcoma-Associated Herpesvirus Gene Expression Program by Using the Viral DNA Replication Inhibitor Cidofovir

  2004cited by this paper
• Fifty years of multicentric Castleman's disease

  2004cited by this paper
• Low dose interferon-α therapy for HIV-associated multicentric Castleman's disease

  2003cited by this paper
• Low dose interferon-alpha therapy for HIV-associated multicentric Castleman's disease.

  2003cited by this paper
• Prevalence of Kaposi's sarcoma‐associated herpesvirus infection in sex workers and women from the general population in Spain

  2002cited by this paper
• A quantification of human cells using an ERV-3 real time PCR assay.

  2001cited by this paper
• Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Gene Expression as Revealed by DNA Arrays

  2001cited by this paper
• Serum viral interleukin-6 in AIDS-related multicentric Castleman disease.

  2001cited by this paper
• Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders.

  2001cited by this paper
• Transcription Program of Human Herpesvirus 8 (Kaposi's Sarcoma-Associated Herpesvirus)

  2001cited by this paper
• Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

  2001cited by this paper
• Human Herpesvirus 8 Open Reading Frame 21 Is a Thymidine and Thymidylate Kinase of Narrow Substrate Specificity That Efficiently Phosphorylates Zidovudine but Not Ganciclovir

  2000cited by this paper
• Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

  2000cited by this paper
• High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

  2000cited by this paper
• Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodéficience humaine.

  2000cited by this paper
• Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients

  2000cited by this paper
• Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions.

  2000cited by this paper
• Successful treatment of human immunodeficiency virus-related Castleman's disease with interferon-alpha.

  2000cited by this paper
• Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.

  1999cited by this paper
• Human Herpesvirus 8-Encoded Thymidine Kinase and Phosphotransferase Homologues Confer Sensitivity to Ganciclovir

  1999cited by this paper
• Cellular Tropism and Viral Interleukin-6 Expression Distinguish Human Herpesvirus 8 Involvement in Kaposi’s Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman’s Disease

  1999cited by this paper
• Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy.

  1998cited by this paper
• The Clinical Behavior of Localized and Multicentric Castleman Disease

  1998cited by this paper
• Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma.

  1998cited by this paper
• Transcription Mapping of the Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Genome in a Body Cavity-Based Lymphoma Cell Line (BC-1)

  1998cited by this paper
• Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.

  1997cited by this paper
• Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients

  1996cited by this paper
• Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

  1995cited by this paper
• Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

  1994cited by this paper
• Vaccines 87 : modern approaches to new vaccines : prevention of AIDS and other viral, bacterial, and parasitic diseases

  1987cited by this paper
• Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders. A progress report.

  1987cited by this paper
• Plasma and cerebrospinal fluid pharmacokinetics of 3′‐azido‐3′‐deoxythymidine: A Novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

  1987cited by this paper
• Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.

  1986cited by this paper
• Sjogren-Larsson syndrome.

  1970cited by this paper

• A viral Achilles' heel for EBV-positive lymphomas.

  2026cites this paper
• KSHV and cancer: understanding the oncogenic machinery for next-generation diagnostic tools and therapies

  2026cites this paper
• 18F-FDG PET/CT metabolic parameters are correlated with clinical features and valuable in clinical stratification management in patients of castleman disease

  2025cites this paper
• Characteristics and outcomes of Kaposi sarcoma herpesvirus–associated inflammatory cytokine syndrome

  2025cites this paper
• Modern Approach to Manage Patients With Kaposi Sarcoma

  2025cites this paper
• A case of KSHV/HHV8-positive large B-cell lymphoma in a background of HIV-negative KSHV/HHV8-positive Multicentric Castleman disease.

  2025cites this paper
• Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients with HIV in the United States.

  2025cites this paper
• Advances in KSHV Research: Molecular Pathogenesis, Immune Evasion, and Evolving Therapeutic Horizon

  2025cites this paper
• Discovery of a small-molecule inhibitor of KSHV lytic replication from the MMV Pandemic Response Box.

  2024cites this paper
• HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus

  2024cites this paper
• The complete Kaposi sarcoma-associated herpesvirus genome induces early-onset, metastatic angiosarcoma in transgenic mice.

  2024cites this paper
• Clinical Significance of Elevated KSHV Viral Load in HIV-Related Kaposi’s Sarcoma Patients in South Africa

  2024cites this paper
• Local radiotherapy for chemotherapy-refractory Kaposi's sarcoma in an HIV-infected patient: A case report and literature review.

  2024cites this paper
• The clinical picture of Castleman disease: a systematic review and meta-analysis

  2024cites this paper
• Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies

  2023cites this paper
• Oncoviruses: How do they hijack their host and current treatment regimes.

  2023cites this paper
• KSHV Viral Protein Kinase Interacts with USP9X to Modulate the Viral Lifecycle

  2023cites this paper
• High Seroprevalence of Kaposi Sarcoma–Associated Herpesvirus in Men Who Have Sex With Men With HIV in the Southern United States

  2023cites this paper
• A Challenging Case of Kaposi Sarcoma Inflammatory Cytokine Syndrome

  2023influential citation
• Hypoxia and hypoxia‐inducible factors in Kaposi sarcoma‐associated herpesvirus infection and disease pathogenesis

  2023cites this paper
• The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

  2022cites this paper
• The clinicopathological features and survival of Castleman disease: a multicenter Turkish study.

  2022cites this paper
• Therapeutic Perspectives in the Systemic Treatment of Kaposi’s Sarcoma

  2022cites this paper
• Efficacy and safety of regimens used for the treatment of multicentric Castleman disease: A systematic review

  2022influential citation
• Approche thérapeutique des maladies de Castleman : l’émergence des thérapies ciblées

  2022cites this paper
• Mechanism of herpesvirus protein kinase UL13 in immune escape and viral replication

  2022cites this paper
• Disseminated Kaposi sarcoma with cytokine release in an AIDS patient.

  2021cites this paper
• Castleman disease

  2021cites this paper
• [HHV-8 Related immunological and hematological diseases].

  2021cites this paper
• Kaposi's Sarcoma‐associated Herpesvirus—Antiviral Treatment

  2021cites this paper
• KSHV/HHV8-Associated Lymphoproliferative Disorders: Lessons Learnt from People Living with HIV

  2021cites this paper
• Recent Advances in Developing Treatments of Kaposi’s Sarcoma Herpesvirus-Related Diseases

  2021cites this paper
• HIV-associated lymphoma—advances in clinical management

  2021cites this paper
• Cancers associated with human gammaherpesviruses

  2021cites this paper
• KSHV/HHV8-mediated hematologic diseases.

  2021cites this paper
• Advances in the Study of Kaposi’s Sarcoma in Human

  2021cites this paper
• The Importance of Early Recognition of KSHV-mediated Syndromes: A Case Report.

  2021cites this paper
• Multicentric Castleman’s disease in HIV patients: a single-center cohort diagnosed from 2008 to 2018

  2021cites this paper
• Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases.

  2021cites this paper
• Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis.

  2021cites this paper
• 'Peeling back the onion layers': the challenge of HIV-associated multicentric Castleman's disease.

  2021cites this paper
• Chapter XX Antiviral Treatment and Cancer Control.

  2021cites this paper
• The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs

  2020cites this paper
• Tocilizumab in Patients with Symptomatic Kaposi sarcoma Herpesvirus (KSHV)- associated Multicentric Castleman disease.

  2020cites this paper
• Regulation of Kaposi’s Sarcoma-Associated Herpesvirus Biology by Host Molecular Chaperones

  2020cites this paper
• Dual infection and recombination of Kaposi sarcoma herpesvirus revealed by whole-genome sequence analysis of effusion samples.

  2020cites this paper
• Castleman病的诊疗进展

  2020cites this paper
• A Rare Case of the Newly Recognized Kaposi Sarcoma Herpesvirus-Associated Disease

  2020cites this paper
• Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

  2020cites this paper
• Allicin and Glycyrrhizic Acid Display Antiviral Activity Against Latent and Lytic Kaposi Sarcoma-associated Herpesvirus

  2020cites this paper
• Peeling back the onion layers ’ : the challenge of HI V-associated multicentric Castleman ’ s disease Multicentric

  2020cites this paper
• Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels.

  2020cites this paper
• Tumor Microenvironment Conditioning by Abortive Lytic Replication of Oncogenic γ-Herpesviruses.

  2020cites this paper
• Overview of Castleman Disease.

  2020cites this paper
• The Potential Clinical Benefit of Tocilizumab Therapy for Patients with HHV-8-infected AIDS-related Multicentric Castleman Disease: A Case Report and Literature Review

  2020cites this paper
• Induction of Kaposi’s Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1

  2019cites this paper
• Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use

  2019cites this paper
• Protocole national de diagnostic et de soins (PNDS) : atrésie de l’œsophage

  2019cites this paper
• Kaposi sarcoma

  2019cites this paper
• Kaposi sarcoma-associated herpesvirus/human herpesvirus 8-associated lymphoproliferative disorders.

  2019cites this paper
• Kaposi Sarcoma-Associated Herpesvirus (KSHV).

  2019cites this paper
• GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus.

  2018cites this paper
• Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.

  2018cites this paper
• KSHV-associated Malignancies: Epidemiology, Pathogenesis, and Advances in Treatment

  2018cites this paper
• HIV‐Associated Cancers and Related Diseases

  2018cites this paper
• Renal failure in pediatric Castleman disease: Four French cases with thrombotic microangiopathy

  2018cites this paper
• Isolated retroperitoneal Castleman's disease: A case report and literature review

  2018cites this paper
• Mediastinal and Hilar Lymphadenopathy

  2018cites this paper
• Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Associated Disease in the AIDS Patient: An Update.

  2018cites this paper
• Human herpesvirus–encoded kinase induces B cell lymphomas in vivo

  2018cites this paper
• Viral Diseases of the Skin

  2017cites this paper
• Kaposi sarcoma herpesvirus pathogenesis

  2017influential citation
• Clinical and scientific challenges in HIV-associated malignancies

  2017cites this paper
• Cancer clinical trials in persons with HIV infection.

  2017cites this paper
• Lymphoproliferative Disorders of the Lung

  2017cites this paper
• HIV-associated Kaposi sarcoma and related diseases

  2017cites this paper
• Experience with Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome in a Large Urban HIV Clinic in the United States: Case Series and Literature Review

  2017cites this paper
• Rituximab Monotherapy in the Management of a Rare Case of an HIV Associated Lymphoproliferative Disorder

  2017cites this paper
• Seroprevalence and viral quantification of Kaposi Sarcoma-associated Herpes Virus (KSHV) in a Human Immunodeficiency Virus (HIV) infected adult South African cohort.

  2017cites this paper
• Kaposi sarcoma herpesvirus-associated cancers and related diseases

  2017cites this paper
• Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV8)

  2017cites this paper
• Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.

  2017influential citation
• Modulation of oncogenic signaling networks by Kaposi’s sarcoma-associated herpesvirus

  2017cites this paper
• Current diagnosis and treatment of Castleman's disease.

  2016cites this paper
• Clinical management of HIV-associated hematologic malignancies

  2016influential citation
• A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination.

  2016cites this paper
• Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function

  2016cites this paper
• Castleman Disease of the Thorax: Clinical, Radiologic, and Pathologic Correlation: From the Radiologic Pathology Archives.

  2016cites this paper
• Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.

  2016cites this paper
• HIV: Treatment and Comorbidity

  2016cites this paper
• Revisión histórica del sarcoma de Kaposi en la era pre-TARAA (terapia antirretroviral altamente activa): evolución con diferentes esquemas de quimioterapia y remisión con el uso de ganciclovir

  2016cites this paper
• [Historical Review of Kaposi sarcoma in pre-HAART era: evolution with different chemotherapy schedules and remission with ganciclovir use].

  2016cites this paper
• Current diagnosis and treatment of Castleman's disease

  2016cites this paper
• The Kaposi's-sarcoma-associated herpesvirus orf35 gene product is required for efficient lytic virus reactivation.

  2016cites this paper
• Recent advances in understanding Kaposi’s sarcoma-associated herpesvirus

  2016cites this paper
• The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients

  2016cites this paper
• Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes

  2016cites this paper
• Update and new approaches in the treatment of Castleman disease

  2016cites this paper
• Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi

  2015cites this paper
• F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus– Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters

  2015influential citation